188 related articles for article (PubMed ID: 8305382)
1. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages.
MacLean MA; Cumming GP; McCall F; Walker ID; Walker JJ
Br J Obstet Gynaecol; 1994 Feb; 101(2):103-6. PubMed ID: 8305382
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome.
Branch DW; Silver R; Pierangeli S; van Leeuwen I; Harris EN
Obstet Gynecol; 1997 Apr; 89(4):549-55. PubMed ID: 9083311
[TBL] [Abstract][Full Text] [Related]
3. Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study.
Ginsberg JS; Brill-Edwards P; Johnston M; Denburg JA; Andrew M; Burrows RF; Bensen W; Cividino A; Long AA
Blood; 1992 Aug; 80(4):975-80. PubMed ID: 1498338
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who have negative test results for lupus anticoagulant and anticardiolipin antibodies.
Silver RM; Pierangeli SS; Edwin SS; Umar F; Harris EN; Scott JR; Branch DW
Am J Obstet Gynecol; 1997 Mar; 176(3):628-33. PubMed ID: 9077618
[TBL] [Abstract][Full Text] [Related]
5. Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss.
Creagh MD; Malia RG; Cooper SM; Smith AR; Duncan SL; Greaves M
J Clin Pathol; 1991 Jan; 44(1):45-7. PubMed ID: 1900070
[TBL] [Abstract][Full Text] [Related]
6. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
7. Incidence of anticardiolipin antibodies and lupus anticoagulant factor among women experiencing unexplained recurrent abortion and intrauterine fetal death.
Al Jameil N; Tyagi P; Al Shenefy A
Int J Clin Exp Pathol; 2015; 8(3):3204-9. PubMed ID: 26045841
[TBL] [Abstract][Full Text] [Related]
8. Lupus anticoagulant and anticardiolipin antibodies in systemic lupus erythematosus.
Saxena R; Saraya AK; Dhot PS; Singh Y; Malaviya AN
Natl Med J India; 1994; 7(4):163-5. PubMed ID: 7950946
[TBL] [Abstract][Full Text] [Related]
9. Anti beta 2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss: prevalence and clinical significance.
Ogasawara M; Aoki K; Matsuura E; Sasa H; Yagami Y
Lupus; 1996 Dec; 5(6):587-92. PubMed ID: 9116701
[TBL] [Abstract][Full Text] [Related]
10. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
Rai R; Cohen H; Dave M; Regan L
BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies and lipoprotein (a) in women with recurrent fetal loss.
Szczepański M; Bauer A; Gardas A; Duchiński T
Int J Gynaecol Obstet; 1998 Apr; 61(1):39-44. PubMed ID: 9622171
[TBL] [Abstract][Full Text] [Related]
12. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population.
Lockwood CJ; Romero R; Feinberg RF; Clyne LP; Coster B; Hobbins JC
Am J Obstet Gynecol; 1989 Aug; 161(2):369-73. PubMed ID: 2504043
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus.
Out HJ; van Vliet M; de Groot PG; Derksen RH
Ann Rheum Dis; 1992 Mar; 51(3):353-7. PubMed ID: 1575581
[TBL] [Abstract][Full Text] [Related]
14. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus.
McHugh NJ; Moye DA; James IE; Sampson M; Maddison PJ
Ann Rheum Dis; 1991 Aug; 50(8):548-52. PubMed ID: 1909518
[TBL] [Abstract][Full Text] [Related]
15. Anticardiolipin antibodies: clinical consequences of "low titers".
Silver RM; Porter TF; van Leeuween I; Jeng G; Scott JR; Branch DW
Obstet Gynecol; 1996 Apr; 87(4):494-500. PubMed ID: 8602297
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations.
Pattison NS; Chamley LW; McKay EJ; Liggins GC; Butler WS
Br J Obstet Gynaecol; 1993 Oct; 100(10):909-13. PubMed ID: 8217972
[TBL] [Abstract][Full Text] [Related]
17. The influence of antiphospholipid antibodies on the pregnancy outcome of patients with recurrent spontaneous abortion.
Heilmann L; von Tempelhoff GF; Kuse S
Clin Appl Thromb Hemost; 2001 Oct; 7(4):281-5. PubMed ID: 11697709
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L
Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674
[TBL] [Abstract][Full Text] [Related]
19. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies.
Rai RS; Clifford K; Cohen H; Regan L
Hum Reprod; 1995 Dec; 10(12):3301-4. PubMed ID: 8822463
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
